Not Signed In - Mylan Announces Final FDA Approval For Finasteride Tablets USP, 5mg
Wed, 20 Dec 2006 08:00 AM EST
... Mylan Laboratories Inc. (NYSE: MYL) today announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Finasteride Tablets USP, 5mg. [click link for full article] ...
Related Topics
- Finasteride
- Carbinoxamine and Pseudoephedrine Tablets
- Vaccine Testing & Approval
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Cyanocobalamin Tablets
- Tacrolimus ointment
- Chlorpheniramine, Pseudoephedrine and Hydrocodone Tablets
- Guaifenesin and Dextromethorphan
- Thiabendazole Tablets
- Neostigmine Tablets
- Haloperidol Tablets
- Amlodipine
- Mammography
- Carbetapentane, Phenylephrine, and Pyrilamine
- Ergoloid Mesylates Sublingual Tablets
- Nystatin Tablets
- Desmopressin Tablets
- Nystatin and Triamcinolone
- Carcinogens
- Isosorbide Dinitrate, Tablets or Extended-Release Tablets or Capsules
email this page
print this page
bookmark this page
feedback on this page
